RAFAEL HOLDINGS, INC. Financing Cash Flow
RAFAEL HOLDINGS, INC. (RFL) reported Financing Cash Flow of -$90.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-04-30 was -$28.00K, a 354.55% decline year-over-year.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-01-31 was -$32.00K.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-10-31 was -$30.00K.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-07-31 was $24.89M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $24.83M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$179.00K.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$15.22M, a 114.65% decline from fiscal 2022.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $103.86M, a 242.81% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-04-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$60.00K derived: sum of 2 quarters · filed 2026-06-11 | -$90.00K 10-Q · filed 2026-06-11 | $24.80M derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$62.00K 10-Q · filed 2026-03-16 | $24.83M derived: sum of 3 quarters · filed 2026-03-16 | $24.84M derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-10-31 | -$30.00K 10-Q · filed 2025-12-12 | $24.86M derived: sum of 2 quarters · filed 2025-12-12 | $24.88M derived: sum of 3 quarters · filed 2026-06-11 | $24.85M derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-07-31 | $24.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $24.91M derived: sum of 2 quarters · filed 2026-06-11 | $24.88M derived: sum of 3 quarters · filed 2026-06-11 | $24.83M 10-K · filed 2025-10-29 |
| 2025-04-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$16.00K derived: sum of 2 quarters · filed 2026-06-11 | -$64.00K 10-Q · filed 2026-06-11 | -$88.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$75.00K 10-Q · filed 2026-03-16 | -$99.00K derived: sum of 3 quarters · filed 2026-03-16 | -$129.00K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | -$48.00K 10-Q · filed 2025-12-12 | -$72.00K derived: sum of 2 quarters · filed 2025-12-12 | -$102.00K derived: sum of 3 quarters · filed 2025-12-12 | -$1.03M derived: sum of 4 quarters · filed 2025-12-12 |
| 2024-07-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$54.00K derived: sum of 2 quarters · filed 2025-10-29 | -$986.00K derived: sum of 3 quarters · filed 2025-10-29 | -$179.00K 10-K · filed 2025-10-29 |
| 2024-04-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | -$962.00K derived: sum of 2 quarters · filed 2025-06-11 | -$155.00K 10-Q · filed 2025-06-11 | -$190.00K derived: sum of 4 quarters · filed 2025-06-11 |
| 2024-01-31 | -$932.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | -$125.00K 10-Q · filed 2025-03-14 | -$160.00K derived: sum of 3 quarters · filed 2025-03-14 | -$186.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-10-31 | $807.00K 10-Q · filed 2024-12-11 | $772.00K derived: sum of 2 quarters · filed 2024-12-20 | $746.00K derived: sum of 3 quarters · filed 2024-12-20 | $595.00K derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-07-31 | -$35.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$61.00K derived: sum of 2 quarters · filed 2024-12-20 | -$212.00K derived: sum of 3 quarters · filed 2024-12-20 | -$15.22M 10-K/A · filed 2024-12-20 |
| 2023-04-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | -$177.00K derived: sum of 2 quarters · filed 2024-06-14 | -$15.18M 10-Q · filed 2024-06-14 | -$9.19M derived: sum of 4 quarters · filed 2024-06-14 |
| 2023-01-31 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | -$15.16M 10-Q · filed 2024-03-14 | -$9.16M derived: sum of 3 quarters · filed 2024-03-14 | -$9.16M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-10-31 | -$15.01M 10-Q · filed 2023-12-14 | -$9.01M derived: sum of 2 quarters · filed 2023-12-14 | -$9.01M derived: sum of 3 quarters · filed 2023-12-14 | -$9.05M derived: sum of 4 quarters · filed 2023-12-14 |
| 2022-07-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $6.00M derived: sum of 2 quarters · filed 2023-10-30 | $5.96M derived: sum of 3 quarters · filed 2023-10-30 | $103.86M 10-K · filed 2023-10-30 |
| 2022-04-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$42.00K derived: sum of 2 quarters · filed 2023-06-13 | $97.87M 10-Q · filed 2023-06-13 | $112.39M derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-01-31 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $97.87M 10-Q · filed 2023-03-14 | $112.40M derived: sum of 3 quarters · filed 2023-03-14 | $114.36M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-10-31 | $97.91M 10-Q · filed 2022-12-13 | $112.44M derived: sum of 2 quarters · filed 2022-12-13 | $114.40M derived: sum of 3 quarters · filed 2022-12-13 | $128.16M derived: sum of 4 quarters · filed 2022-12-13 |
| 2021-07-31 | $14.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $16.49M derived: sum of 2 quarters · filed 2022-10-31 | $30.25M derived: sum of 3 quarters · filed 2022-10-31 | $30.30M 10-K · filed 2022-10-31 |
| 2021-04-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $15.73M derived: sum of 2 quarters · filed 2022-06-14 | $15.77M 10-Q · filed 2022-06-14 | $15.77M derived: sum of 4 quarters · filed 2022-06-14 |
| 2021-01-31 | $13.77M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | $13.81M 10-Q · filed 2022-03-17 | $13.81M derived: sum of 3 quarters · filed 2022-03-17 | $13.83M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-10-31 | $43.00K 10-Q/A · filed 2022-02-28 | $43.00K derived: sum of 2 quarters · filed 2022-02-28 | $63.00K derived: sum of 3 quarters · filed 2022-02-28 | |
| 2020-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $20.00K derived: sum of 2 quarters · filed 2021-10-18 | -$96.00K 10-K · filed 2021-10-18 | |
| 2020-04-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | -$96.00K 10-Q · filed 2021-06-14 | ||
| 2020-01-31 | -$116.00K 10-Q · filed 2021-03-17 | |||
| 2019-07-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $62.00K derived: sum of 2 quarters · filed 2020-10-29 | $30.77M derived: sum of 3 quarters · filed 2020-10-29 | $30.89M 10-K · filed 2020-10-29 |
| 2019-04-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $30.74M derived: sum of 2 quarters · filed 2020-06-09 | $30.85M 10-Q · filed 2020-06-09 | |
| 2019-01-31 | $30.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | $30.83M 10-Q · filed 2020-03-05 | ||
| 2018-10-31 | $118.00K 10-Q · filed 2019-12-09 | |||
| 2018-07-31 | $1.75M 10-K · filed 2019-10-04 | |||
| 2018-01-31 | $900.00K 10-Q · filed 2019-03-12 | |||
| 2017-07-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $2.93M derived: sum of 2 quarters · filed 2018-10-15 | $22.26M 10-K · filed 2018-10-15 | |
| 2017-04-30 | $441.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | $19.77M 10-Q · filed 2018-06-11 | ||
| 2017-01-31 | $19.33M 10-Q · filed 2018-03-12 | |||
| 2016-07-31 | $265.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |